Peripheral artery disease is an abnormality that restricts the blood flow of arteries to the arms, stomach, and commonly, legs. Deposition of fatty substances on the wall of the arteries thickens them and restricts blood flow. Symptoms of peripheral artery disease include numbness in the legs, pain, and others.
The incidence of peripheral artery disease has been growing rapidly worldwide. Patients often prefer revascularization as it is a better treatment approach. Surgical revascularizations and surgical grafting have been carried out for a long time. The trend of revascularizations has increased for patients who are unfit for surgery. The use of drug eluting balloons for revascularization therapy for the treatment of peripheral artery diseases represents an emerging trend around the globe.
A drug eluting balloon is a semi-compliant angioplasty balloon that is surrounded by an anti-proliferative medicine. The medicine is ejected to the vessel wall during the inflation of the balloon. The active substance of the balloon is highly lipophilic (dissolved in lipids or fats). The drug eluting balloon homogeneously delivers the drug to the vessel and provides treatment for peripheral artery disease.
The global drug eluting balloon for peripheral artery disease market is primarily driven by a rise in the cases of peripheral artery disease in the world, diagnosis and treatment rate of peripheral artery diseases, and development of health care infrastructure. However, low availability of drug eluting balloons, high price of treatment, stringent regulatory landscape, and intellectual property rights laws are likely to hamper the growth of the global drug eluting balloon for peripheral artery diseases market in the near future. Technological advancements, increase in R&D investment, and major acquisitions among key players are estimated to provide attractive opportunities to the global drug eluting balloon for peripheral artery disease market during the forecast period.
In terms of drug coating technology, the global drug eluting balloon for peripheral artery disease market can be segmented into paccocath, endurocoat, freepac, Tranxpax, and others. The others segment is anticipated to expand at a rapid CAGR during the forecast period, owing to the introduction of new drug eluting balloons across the world. Based on drug dose, the global drug eluting balloon for peripheral artery diseases market can be classified into 3 µg/mm2, 2 µg/mm2, and others. The 3 µg/mm2 segment is estimated to constitute a significant market share in 2017, followed by the 2 µg/mm2 and others segments. In terms of end-user, the global drug eluting balloon for peripheral artery disease market can be categorized into hospitals, ambulatory surgery centers, catheterization laboratories, and others. The ambulatory surgery centers segment is expected to expand at a rapid CAGR during the forecast period, due to the emergence of ambulatory surgery centers globally.
Based on geography, the global drug eluting balloon for peripheral artery disease market can be classified into North America, Europe, Asia Pacific, Latin America, and others. North America accounted for a prominent share of the drug eluting balloon for peripheral artery disease market in 2017. The market in the region is estimated to expand at a significant growth rate in the near future. Europe held a key share of the drug eluting balloon for peripheral artery diseases market in Europe in 2017. However, the market share of the region is projected to decline in the coming years. Recent approvals of drug eluting balloons in North America are likely to represent noteworthy growth rate in future. Factors such as a large patient population, developing health care infrastructure, and technological advancements are expected to drive the drug eluting balloon for peripheral artery diseases market in Asia Pacific in the near future. However, low availability of drug eluting balloons, low product awareness, and weak health care infrastructure are projected to hamper the drug eluting balloon for peripheral artery disease market in Latin America and Middle East & Africa.
Key players operating in the global drug eluting balloon for peripheral artery disease market are Cook Medical, BD, Medtronic, Bayer AG, Eurocor, Cardionovum, and others.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.
TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.
Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:
Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.
Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.
Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.